An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer Female
Interventions: DRUG: surufatinib + fulvestrant + chidamide
Sponsor: The First Affiliated Hospital of Zhengzhou University